US Stock MarketDetailed Quotes

IMMU Immunomedics

Watchlist

0.000
0.0000.00%

Close Sep 27 09:30 ET

0Market Cap0.00P/E (TTM)

Immunomedics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

(Q1)Mar 31, 2019

(FY)Dec 31, 2018

(Q4)Jun 30, 2018

(Q3)Mar 31, 2018

Total revenue

20.07M

295K

-23.58%295K

-39.84%386K

-63.56%482.23K

Operating revenue

--20.07M

--0

--295K

-23.58%295K

--0

-39.84%386K

-63.56%482.23K

Cost of revenue

1.67M

171.47%254.87M

171.06%74.82M

138.69%68.96M

79.66%93.89M

128.94%27.6M

128.80%28.89M

Gross profit

18.41M

-171.15%-254.58M

-173.82%-74.52M

-142.74%-68.96M

-90.95%-93.89M

-138.43%-27.22M

-151.32%-28.41M

Operating expense

6.33%71.42M

2.91%81.97M

38.73%70.26M

-33.56%16.73M

93.20%17.81M

67.17M

79.65M

68.93%50.65M

64.47%25.18M

-14.76%9.22M

Selling and administrative expenses

102.57%28.86M

-9.01%19.54M

38.73%70.26M

-33.56%16.73M

93.20%17.81M

--14.25M

--21.48M

68.93%50.65M

64.47%25.18M

-14.76%9.22M

-Selling and marketing expense

103.01%12.88M

2.36%8.07M

33.40%26.46M

107.20%6.3M

150.76%5.93M

--6.35M

--7.88M

2,171.94%19.83M

1,692.90%3.04M

682.12%2.37M

-General and administrative expense

102.22%15.97M

-15.61%11.47M

42.15%43.8M

-52.89%10.43M

73.34%11.88M

--7.9M

--13.6M

5.86%30.81M

46.23%22.14M

-34.81%6.85M

Research and development costs

-19.58%42.56M

7.32%62.43M

----

--52.92M

--58.17M

----

Operating profit

21.08%-53.01M

-2.91%-81.97M

-124.75%-324.84M

-74.16%-91.25M

-130.61%-86.77M

-67.17M

-79.65M

-82.61%-144.54M

-96.06%-52.39M

-70.10%-37.63M

Net non-operating interest income expense

-53.50%-13.49M

-43.26%-11.11M

-133.49%-32.48M

-217.53%-8.39M

22.71%-7.55M

-8.79M

-7.76M

-157.80%-13.91M

715.72%7.14M

-648.51%-9.77M

Non-operating interest income

-59.40%747K

10.17%2.43M

28.66%7.86M

-54.62%1.62M

94.34%2.2M

--1.84M

--2.2M

1,316.71%6.11M

1,585.96%3.57M

1,649.14%1.13M

Non-operating interest expense

33.95%14.23M

35.94%13.54M

101.51%40.34M

6.07%10.01M

-10.58%9.75M

--10.63M

--9.96M

265.27%20.02M

588.53%9.43M

695.67%10.9M

Other net income (expense)

101.01%697K

-182.37%-71.63M

132.99%11.84M

Gain on sale of security

----

102.04%1.4M

-132.45%-58.96M

127.61%9.91M

Special income (charges)

----

--0

----

---707K

---12.66M

--1.93M

-Less:Other special charges

----

--707K

--12.66M

---1.93M

Income before tax

12.45%-66.5M

-6.49%-93.08M

-126.51%-357.32M

14.75%-99.64M

-165.26%-94.32M

-75.95M

-87.4M

-2.94%-157.75M

-119.51%-116.88M

40.06%-35.56M

Income tax

680.00%156K

Net income

12.45%-66.5M

-6.49%-93.08M

-126.51%-357.32M

14.87%-99.64M

-165.26%-94.32M

-75.95M

-87.4M

-2.92%-157.75M

-119.72%-117.04M

40.06%-35.56M

Net income continuous Operations

12.45%-66.5M

-6.49%-93.08M

-126.51%-357.32M

14.87%-99.64M

-165.26%-94.32M

---75.95M

---87.4M

-2.92%-157.75M

-119.72%-117.04M

40.06%-35.56M

Minority interest income

-31K

52.24%-32K

-59.26%-129K

-184.09%-31K

-160.61%-31K

-67K

-35.00%-81K

21.13%-10.91K

17.05%-11.9K

Net income attributable to the parent company

12.49%-66.47M

-6.54%-93.05M

-126.55%-357.19M

14.89%-99.61M

-165.27%-94.29M

-75.95M

-87.34M

-2.91%-157.67M

-119.75%-117.03M

40.06%-35.55M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

12.49%-66.47M

-6.54%-93.05M

-126.55%-357.19M

14.89%-99.61M

-165.27%-94.29M

-75.95M

-87.34M

-2.91%-157.67M

-119.75%-117.03M

40.06%-35.55M

Basic earnings per share

25.00%-0.3

4.35%-0.44

-119.05%-1.84

26.47%-0.5

-133.33%-0.49

-0.4

-0.46

42.86%-0.84

-41.67%-0.68

61.82%-0.21

Diluted earnings per share

25.00%-0.3

4.35%-0.44

-119.05%-1.84

26.47%-0.5

-133.33%-0.49

-0.4

-0.46

42.86%-0.84

-41.67%-0.68

61.82%-0.21

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019	(Q1)Mar 31, 2019	(FY)Dec 31, 2018	(Q4)Jun 30, 2018	(Q3)Mar 31, 2018
Total revenue	20.07M	0	295K	-23.58%295K	0	0	0	0	-39.84%386K	-63.56%482.23K
Operating revenue	--20.07M	--0	--295K	-23.58%295K	--0	--0	--0	--0	-39.84%386K	-63.56%482.23K
Cost of revenue	1.67M		171.47%254.87M	171.06%74.82M	138.69%68.96M	0		79.66%93.89M	128.94%27.6M	128.80%28.89M
Gross profit	18.41M		-171.15%-254.58M	-173.82%-74.52M	-142.74%-68.96M	0		-90.95%-93.89M	-138.43%-27.22M	-151.32%-28.41M
Operating expense	6.33%71.42M	2.91%81.97M	38.73%70.26M	-33.56%16.73M	93.20%17.81M	67.17M	79.65M	68.93%50.65M	64.47%25.18M	-14.76%9.22M
Selling and administrative expenses	102.57%28.86M	-9.01%19.54M	38.73%70.26M	-33.56%16.73M	93.20%17.81M	--14.25M	--21.48M	68.93%50.65M	64.47%25.18M	-14.76%9.22M
-Selling and marketing expense	103.01%12.88M	2.36%8.07M	33.40%26.46M	107.20%6.3M	150.76%5.93M	--6.35M	--7.88M	2,171.94%19.83M	1,692.90%3.04M	682.12%2.37M
-General and administrative expense	102.22%15.97M	-15.61%11.47M	42.15%43.8M	-52.89%10.43M	73.34%11.88M	--7.9M	--13.6M	5.86%30.81M	46.23%22.14M	-34.81%6.85M
Research and development costs	-19.58%42.56M	7.32%62.43M	----	----	----	--52.92M	--58.17M	----	----	----
Operating profit	21.08%-53.01M	-2.91%-81.97M	-124.75%-324.84M	-74.16%-91.25M	-130.61%-86.77M	-67.17M	-79.65M	-82.61%-144.54M	-96.06%-52.39M	-70.10%-37.63M
Net non-operating interest income expense	-53.50%-13.49M	-43.26%-11.11M	-133.49%-32.48M	-217.53%-8.39M	22.71%-7.55M	-8.79M	-7.76M	-157.80%-13.91M	715.72%7.14M	-648.51%-9.77M
Non-operating interest income	-59.40%747K	10.17%2.43M	28.66%7.86M	-54.62%1.62M	94.34%2.2M	--1.84M	--2.2M	1,316.71%6.11M	1,585.96%3.57M	1,649.14%1.13M
Non-operating interest expense	33.95%14.23M	35.94%13.54M	101.51%40.34M	6.07%10.01M	-10.58%9.75M	--10.63M	--9.96M	265.27%20.02M	588.53%9.43M	695.67%10.9M
Other net income (expense)								101.01%697K	-182.37%-71.63M	132.99%11.84M
Gain on sale of security	----	----	----	----	----	----	----	102.04%1.4M	-132.45%-58.96M	127.61%9.91M
Special income (charges)	----	----	--0	--0	--0	----	----	---707K	---12.66M	--1.93M
-Less:Other special charges	----	----	----	----	----	----	----	--707K	--12.66M	---1.93M
Income before tax	12.45%-66.5M	-6.49%-93.08M	-126.51%-357.32M	14.75%-99.64M	-165.26%-94.32M	-75.95M	-87.4M	-2.94%-157.75M	-119.51%-116.88M	40.06%-35.56M
Income tax	0	0	0	0	0	0	0	0	680.00%156K	0
Net income	12.45%-66.5M	-6.49%-93.08M	-126.51%-357.32M	14.87%-99.64M	-165.26%-94.32M	-75.95M	-87.4M	-2.92%-157.75M	-119.72%-117.04M	40.06%-35.56M
Net income continuous Operations	12.45%-66.5M	-6.49%-93.08M	-126.51%-357.32M	14.87%-99.64M	-165.26%-94.32M	---75.95M	---87.4M	-2.92%-157.75M	-119.72%-117.04M	40.06%-35.56M
Minority interest income	-31K	52.24%-32K	-59.26%-129K	-184.09%-31K	-160.61%-31K	0	-67K	-35.00%-81K	21.13%-10.91K	17.05%-11.9K
Net income attributable to the parent company	12.49%-66.47M	-6.54%-93.05M	-126.55%-357.19M	14.89%-99.61M	-165.27%-94.29M	-75.95M	-87.34M	-2.91%-157.67M	-119.75%-117.03M	40.06%-35.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	12.49%-66.47M	-6.54%-93.05M	-126.55%-357.19M	14.89%-99.61M	-165.27%-94.29M	-75.95M	-87.34M	-2.91%-157.67M	-119.75%-117.03M	40.06%-35.55M
Basic earnings per share	25.00%-0.3	4.35%-0.44	-119.05%-1.84	26.47%-0.5	-133.33%-0.49	-0.4	-0.46	42.86%-0.84	-41.67%-0.68	61.82%-0.21
Diluted earnings per share	25.00%-0.3	4.35%-0.44	-119.05%-1.84	26.47%-0.5	-133.33%-0.49	-0.4	-0.46	42.86%-0.84	-41.67%-0.68	61.82%-0.21
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data